Standing Stone, Inc. and PGXL Laboratories Announce Collaboration

WESTPORT, Conn., April 26 /PRNewswire/ -- Standing Stone, Inc., with over 300 clients nationwide, which manage 200,000 to 400,000 patients annually, is the leading supplier of secure, web-based applications, that provide decision support tools to health care professionals engaged in disease state management. Standing Stone today announced their partnership with PGXL Laboratories, a leading clinical testing laboratory specializing in warfarin testing and results analysis.

PGXL Laboratories in Louisville, Kentucky is already leading advances in pharmacogenetic testing that are changing the way physicians prescribe warfarin to their patients today. PGXL leadership is leading the development of guidelines for the application of pharmacogenetic testing in health care.

"Standing Stone is proud to team with a state-of-the-art-testing laboratory like PGXL Laboratories," said Albert J. Bartosic, Chief Executive Officer of Standing Stone. "Adding this critical diagnostic component to our popular anti-coagulation software, positions our company as a leader in the fight to improve patient safety and simplify the management of patients on warfarin."

"With our first-of-its-kind testing technology, effective warfarin dosing can be reached sooner and with a greater degree of safety," said Roland Valdes, Jr., Ph.D., University of Louisville School of Medicine and President of PGXL Laboratories. "We've developed technologies that physicians can use to adjust warfarin dosing recommendations that can help reduce the risk for potentially fatal adverse drug reactions," he added.

PGXL Laboratories will participate in Standing Stone's User Group Meeting at the Anti-Coagulation Forum Meeting in Chicago next month.

About Standing Stone, Inc.

Standing Stone, founded in 1998, is a disease state management company dedicated to enhancing the quality of care provided to patients who require long-term therapy for chronic disease management. Standing Stone's e-suite of applications, CoagClinic, CholesterolClinic, DMClinic and CHFClinic, provide health care professionals the tools they need to effectively administer chronic disease therapy while improving outcomes, reducing overhead costs and optimizing provider remuneration. More information is available at http://www.standingstoneinc.com/ .

About PGXL Laboratories

PGXL Laboratories was the first CLIA-certified, high complexity laboratory, specializing in clinical pharmacogenetics. PGXL Laboratories provides unparalleled analytical and interpretative services. PGXL Laboratories is led by recognized leaders in clinical pharmacogenetics, and is outfitted with accurate, state-of-the-art equipment, providing prompt results and detailed analysis for physicians and their staffs. For more information, visit http://www.pgxlab.com/ .